Schedule of carrying amounts and estimated fair values of the financial instruments |
Additional information regarding the methods and assumptions used to estimate the fair value of the financial statements can be found in our Annual Report. The following tables show the carrying amounts and estimated fair values of the Company’s financial instruments (dollars in thousands): | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements at June 30, 2025 using | | | Carrying Value | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Fair Value | FINANCIAL ASSETS: | | | | | | | | | | | | | | | | Cash and restricted cash | | $ | 11,677 | | $ | 11,677 | | $ | — | | $ | — | | $ | 11,677 | Loans, net | | | 91,063 | | | — | | | — | | | 88,673 | | | 88,673 | Investment in joint venture | | | 873 | | | — | | | — | | | 873 | | | 873 | Other investments | | | 1,096 | | | — | | | — | | | 1,096 | | | 1,096 | Accrued interest receivable | | | 424 | | | — | | | — | | | 424 | | | 424 | Servicing assets | | | 179 | | | — | | | — | | | 179 | | | 179 | FINANCIAL LIABILITIES: | | | | | | | | | | | | | | | | Other secured borrowings | | | 6 | | | — | | | — | | | 6 | | | 6 | Debt certificates payable | | | 94,620 | | | — | | | — | | | 94,116 | | | 94,116 | Other financial liabilities | | | 123 | | | — | | | — | | | 123 | | | 123 |
| | | | | | | | | | | | | | | | | | | | | Fair Value Measurements at December 31, 2024 using | | | Carrying Value | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Fair Value | FINANCIAL ASSETS: | | | | | | | | | | | | | | | | Cash and restricted cash | | $ | 10,771 | | $ | 10,771 | | $ | — | | $ | — | | $ | 10,771 | Certificates of deposit | | | 1,304 | | | — | | | 1,308 | | | — | | | 1,308 | Loans, net | | | 93,171 | | | — | | | — | | | 90,684 | | | 90,684 | Investments in joint venture | | | 873 | | | — | | | — | | | 873 | | | 873 | Other investments | | | 1,082 | | | — | | | — | | | 1,082 | | | 1,082 | Accrued interest receivable | | | 447 | | | — | | | — | | | 447 | | | 447 | Servicing assets | | | 177 | | | — | | | — | | | 177 | | | 177 | FINANCIAL LIABILITIES: | | | | | | | | | | | | | | | | Other secured borrowings | | | 6 | | $ | — | | $ | — | | $ | 6 | | $ | 6 | Debt certificates payable | | | 95,073 | | | — | | | — | | | 94,031 | | | 94,031 | Other financial liabilities | | | 479 | | | — | | | — | | | 479 | | | 479 |
|
Schedule of fair value of assets measured on a nonrecurring basis |
The following table presents the fair value of assets measured on a nonrecurring basis (dollars in thousands): | | | | | | | | | | | | | | | Fair Value Measurements Using: | | | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Significant Unobservable Inputs (Level 3) | | Total | Assets at June 30, 2025: | | | | | | | | | | | | | Collateral-dependent impaired loans (net of allowance and discount) | | $ | — | | $ | — | | $ | 7,236 | | $ | 7,236 | Discounted cash flow loans (net of allowance and discount) | | | — | | | — | | | 7,105 | | | 7,105 | Investment in joint venture | | | — | | | — | | | 873 | | | 873 | Other investments | | | — | | | — | | | 1,096 | | | 1,096 | Foreclosed assets (net of allowance) | | | — | | | — | | | 301 | | | 301 | Total | | $ | — | | $ | — | | $ | 16,611 | | $ | 16,611 | | | | | | | | | | | | | | Assets at December 31, 2024: | | | | | | | | | | | | | Collateral-dependent impaired loans (net of allowance and discount) | | $ | — | | $ | — | | $ | 9,535 | | $ | 9,535 | Discounted cash flow loans (net of allowance and discount) | | | — | | | — | | | 7,133 | | | 7,133 | Investments in joint venture | | | — | | | — | | | 873 | | | 873 | Other investments | | | — | | | — | | | 1,082 | | | 1,082 | Foreclosed assets (net of allowance) | | | — | | | — | | | 301 | | | 301 | Total | | $ | — | | $ | — | | $ | 18,924 | | $ | 18,924 |
|
Summary of valuation methodologies used to measure the fair value adjustments for Level 3 assets recorded at fair value on a nonrecurring basis |
The table below summarizes the valuation methodologies used to measure the fair value adjustments for Level 3 assets recorded at fair value on a nonrecurring basis (dollars in thousands): | | | | | | | | | | June 30, 2025 | Assets | | Fair Value (in thousands) | | Valuation Techniques | | Unobservable Input | | Range (Weighted Average) | Collateral dependent loans | | $ | 7,236 | | Discounted appraised value | | Selling cost / Estimated market decrease | | 10% (10%) | Other impaired loans | | | 7,105 | | Discounted future cash flows | | Discount rate | | 4% (4%) | Investment in joint venture | | | 873 | | Internal evaluations | | Estimated future market value | | 0% (0%) | Other investments | | | 1,096 | | Internal evaluations | | Indications of non-performance by insurance companies | | 0% (0%) | Foreclosed Assets | | | 301 | | Internal evaluations | | Selling cost | | 6% (6%) |
| | | | | | | | | | December 31, 2024 | Assets | | Fair Value (in thousands) | | Valuation Techniques | | Unobservable Input | | Range (Weighted Average) | Impaired loans | | $ | 9,535 | | Discounted appraised value | | Selling cost / Estimated market decrease | | 10% (10%) | Other impaired loans | | | 7,133 | | Discounted future cash flows | | Discount rate | | 4% (4%) | Investments in joint venture | | | 873 | | Internal evaluations | | Estimated future market value | | 0% (0%) | Other investments | | | 1,082 | | Internal evaluations | | Indications of non-performance by insurance companies | | 0% (0%) | Foreclosed assets | | | 301 | | Internal evaluations | | Selling cost | | 6% (6%) |
|